Drugs / Autologous hematopoietic stem cell infusion
Autologous hematopoietic stem cell infusion
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07127289 | Aug 2025 → Aug 2027 expected | — | Institute of Hematology & Blood Diseases Hospital, China | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Autologous hematopoietic stem cell infusion | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07127289 ↗ |
| Modality | Cell therapy | “Autologous hematopoietic stem cell infusion” NCT07127289 ↗ |